FDA Allows Sale of Abortion Pills at Retail Pharmacies

Reprotection is appalled that the U.S. Food and Drug Administration is gambling with women’s lives by allowing retail pharmacies to dispense the abortion pill mifepristone. As of January 3, the FDA will no longer enforce a rule requiring women to obtain the first drug in the chemical abortion pill regimen at a clinic or a

READ MORE

Dangerous New Trends with Chemical Abortions

Pro-lifers have long warned about the severe risks chemical abortion pills pose to women’s safety, but now, after the overturn of Roe, the abortion industry has upped its game when it comes to getting this dangerous drug into the hands of women. And recently, businesses that offer abortions have even gone so far as to

READ MORE

Reprotection’s Strategy After the 2022 Midterm Elections

With the Supreme Court’s June decision in Dobbs v. Jackson Women’s Health Services returning regulatory authority over abortion to individual states, several referendums were on state ballots during the 2022 midterm elections. States like California and Michigan passed initiatives that enshrined abortion access into their constitutions, whereas Kentucky voted down a pro-life proposal. The measure,

READ MORE